SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000320017-24-000016
Filing Date
2024-04-29
Accepted
2024-04-29 16:51:43
Documents
7
Period of Report
2024-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a-20240429.htm DEF 14A 871213
2 djmnew.jpg GRAPHIC 7742
3 lisata.jpg GRAPHIC 16409
4 proxycard-pc4_pagex2a.jpg GRAPHIC 527659
5 proxycardfinaltuesday0423a.jpg GRAPHIC 533736
6 pvp104042024.jpg GRAPHIC 789755
7 pvp204042024.jpg GRAPHIC 772621
  Complete submission text file 0000320017-24-000016.txt   4517331
Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Filer) CIK: 0000320017 (see all company filings)

IRS No.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33650 | Film No.: 24892084
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)